Currently, his lab is working on elucidating the role of bacterial cupredoxins and cytochromes in cancer regression and arresting cell cycle progression [REF].
In 2008, Prof. Chakrabarty co-founded a second biopharmaceutical discovery company, Amrita Therapeutics Ltd., registered in Ahmedabad, Gujarat, to develop therapies, vaccines, and diagnostics effective against cancers and/or other major public health threats derived from bacterial products found in the human body [REF].